| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
https://www.bloomberg.com/news/articles/2025-10-27/blackstone-deploys-private-credit-to-take-out-signant-loans
Private equity firms, including Blackstone, are exploring bids for UnitedHealth's UK Optum unit just two years after the EM...
TD Cowen analyst Bill Katz maintains Blackstone (NYSE:BX) with a Buy and lowers the price target from $208 to $205.
Blackstone reported strong Q3 results with bullish outlook. Analyst reiterates Market Outperform rating and $195 price target.
Four Roses, Six Flags, and Trump's potential Quantum investments: This week's deal activity involves big bets across va...
Piper Sandler analyst Crispin Love maintains Blackstone (NYSE:BX) with a Neutral and lowers the price target from $173 to $168.
https://news.sky.com/story/blackstone-among-suitors-for-unitedhealth-owned-optum-uk-13456471
Barclays analyst Benjamin Budish maintains Blackstone (NYSE:BX) with a Equal-Weight and lowers the price target from $171 to...
JP Morgan analyst Kenneth Worthington maintains Blackstone (NYSE:BX) with a Neutral and lowers the price target from $177 to...